PT  - JOURNAL ARTICLE
AU  - Zhang, Stephen X.
AU  - Miller, Saylor O.
AU  - Xu, Wen
AU  - Yin, Allen
AU  - Chen, Bryan Z.
AU  - Delios, Andrew
AU  - Dong, Rebecca Kechen
AU  - Chen, Richard Z.
AU  - McIntyre, Roger S.
AU  - Wan, Xue
AU  - Wang, Senhu
AU  - Chen, Jiyao
TI  - Meta-Analytic Evidence of Depression and Anxiety in Eastern Europe during the COVID-19 Pandemic
AID  - 10.1101/2021.06.21.21259227
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.21.21259227
4099  - http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259227.short
4100  - http://medrxiv.org/content/early/2021/06/25/2021.06.21.21259227.full
AB  - Objective To perform a systematic and meta-analysis on the prevalence rates of mental health symptoms including anxiety and depression during the COVID-19 pandemic in the general population in Eastern Europe, as well as three select sub-populations: students, general healthcare workers, and frontline healthcare workers.Data sources Studies in PubMed, Embase, Web of Science, Psycinfo, and medRxiv up to February 6, 2021.Eligibility criteria and data analysis Prevalence rates of mental health symptoms in the general population and key sub-populations during the COVID-19 pandemic in Eastern Europe. Data were pooled using a random-effects meta-analysis to estimate the prevalence rates of anxiety and depression.Results The meta-analysis identifies and includes 21 studies and 26 independent samples in Eastern Europe. Poland (n=4), Serbia (n=4), Russia (n=3), and Croatia (n=3) had the greatest number of studies. To our knowledge, no studies have been conducted in eleven Eastern European countries including Hungary, Slovakia, and Slovenia. The pooled prevalence of anxiety in 18 studies with 22 samples was 30% (95% CI: 24% – 37%) and pooled prevalence of depression in 18 studies with 23 samples was 27% (95% CI: 21% – 34%).Implications The cumulative evidence from the meta-analysis reveals high prevalence rates of clinically significant symptoms during the COVID-19 pandemic in Eastern Europe. The findings suggest evidence of a potential mental health crisis in Eastern Europe during the ongoing COVID-19 pandemic. Our synthesis also reveals a relative lack of studies in certain Eastern European countries as well as high heterogeneities among the existing studies, calling for more effort to achieve evidence-based mental healthcare in Eastern Europe.HighlightsThe pooled prevalence of anxiety and depression were 30% and 27% in Eastern Europe, respectively.Trial registration CRD42020224458Competing Interest StatementThe authors have declared no competing interest.Clinical TrialCRD42020224458Funding StatementJiyao Chen has received $5000 research support from College of Business Oregon State University.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, J.C., upon reasonable request.